HopeStage
Back to all studies
CompletedNCT01220440

Methylphenidate, Dextroamphetamine, or Placebo for Children With ADHD

About this titleRead the official source — NCT01220440

This study evaluated the effectiveness of Methylphenidate for people with ADHD.

Medication studyAges 9–14Norway
The study in practice

Understand this study

What did researchers investigate?

This study evaluated the effectiveness of Methylphenidate for people with ADHD.

Who was this study for?

Listed age limits: 9 years to 14 years.

Listed locations
Fredrikstad and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2006
Recruitment status
Completed
Enrollment listed in the registry
36
Sponsor
Ostfold Hospital Trust
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Norway
Age range
From 9 Years to 14 Years
Official registry ID
NCT01220440
Official title
Show the full official title

Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Fredrikstad

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

This study evaluated the effectiveness of Methylphenidate for people with ADHD.

Who is behind this study?

The study sponsor is Ostfold Hospital Trust, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Methylphenidate, Placebo and Dextroamphetamine.

Who was this study for?

Listed age limits: 9 years to 14 years.

Want to explore more studies?

Explore studies